Drugs / Allogenic fetal mesenchymal stem cells from umbilical cord
last change Dec 2025 re-read 3 minutes ago

Allogenic fetal mesenchymal stem cells from umbilical cord

Cell therapy

Developed for
bronchopulmonary dysplasia
Investigated by
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06270199 Jan 2024 → Dec 2025 overdue bronchopulmonary dysplasia Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Allogenic fetal mesenchymal stem cells from umbilical cord ClinicalTrials.gov intervention name — accepted as the source's own label NCT06270199 ↗
Modality Cell therapy “Allogenic fetal mesenchymal stem cells from umbilical cord - three infusions” NCT06270199 ↗